OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
413957

Ma Kuang Healthcare Holding Ltd

Healthcare Facilities & ServicesVerified

Ma Kuang Healthcare Holding Ltd has a debt-to-equity ratio of 1.13, indicating a moderate level of leverage, and a current ratio of 0.57, suggesting potential liquidity constraints. The company's free cash flow is 97,192,000 TWD, but its operating cash flow is 238,899,000 TWD, showing that it generates positive cash from operations. The company's profitability is weak, with a return on equity of -0.1518 and a return on assets of -0.0486, both significantly below the industry median for Healthcare Facilities & Services. This indicates that the company is not generating returns that meet the cost of capital or industry benchmarks. Ma Kuang Healthcare's revenue is concentrated in its Singapore TCM Clinics and Tianjin Makuang Medical Chain segments, with no disclosed geographic diversification. The company operates approximately 30 TCM clinics in Singapore and has Medicare insurance designated community hospitals in Tianjin, but there is no indication of international expansion or diversification. The company's growth trajectory is uncertain, with a reported revenue of 1,092,508,000 TWD, which is below the analyst estimate of 942,569,000 TWD. The negative operating income of 44,371,000 TWD and net loss of 67,082,000 TWD suggest that the company is not currently growing profitably. The risk assessment indicates a medium liquidity risk and a low dilution risk. However, the company's net cash is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth without external financing. Recent financial filings show that the company has a long-term debt of 501,152,000 TWD and a capital expenditure of -25,089,000 TWD, indicating that it is not investing in new assets. There are no recent transcripts or filings indicating strategic changes or new initiatives.

30-day price · 4139-1.85 (-7.4%)
Low$23.00High$25.40Close$23.05As of21 May, 00:00 UTC
Profile
CompanyMa Kuang Healthcare Holding Ltd
Ticker4139.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Ma Kuang Healthcare Holding Ltd provides Traditional Chinese Medicine (TCM), western medicine, medical cosmetology, health management, and health products through its clinics and retail operations in Singapore and Tianjin.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Ma Kuang Healthcare Holding Ltd has a debt-to-equity ratio of 1.13, indicating a moderate level of leverage, and a current ratio of 0.57, suggesting potential liquidity constraints. The company's free cash flow is 97,192,000 TWD, but its operating cash flow is 238,899,000 TWD, showing that it generates positive cash from operations. The company's profitability is weak, with a return on equity of -0.1518 and a return on assets of -0.0486, both significantly below the industry median for Healthcare Facilities & Services. This indicates that the company is not generating returns that meet the cost of capital or industry benchmarks. Ma Kuang Healthcare's revenue is concentrated in its Singapore TCM Clinics and Tianjin Makuang Medical Chain segments, with no disclosed geographic diversification. The company operates approximately 30 TCM clinics in Singapore and has Medicare insurance designated community hospitals in Tianjin, but there is no indication of international expansion or diversification. The company's growth trajectory is uncertain, with a reported revenue of 1,092,508,000 TWD, which is below the analyst estimate of 942,569,000 TWD. The negative operating income of 44,371,000 TWD and net loss of 67,082,000 TWD suggest that the company is not currently growing profitably. The risk assessment indicates a medium liquidity risk and a low dilution risk. However, the company's net cash is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth without external financing. Recent financial filings show that the company has a long-term debt of 501,152,000 TWD and a capital expenditure of -25,089,000 TWD, indicating that it is not investing in new assets. There are no recent transcripts or filings indicating strategic changes or new initiatives.
Key takeaways
  • Ma Kuang Healthcare Holding Ltd is a TCM and health services provider with operations in Singapore and Tianjin.
  • The company is currently unprofitable, with a negative return on equity and return on assets.
  • The company's liquidity position is weak, with a current ratio of 0.57 and a negative net cash position after debt.
  • The company's growth is uncertain, with revenue below analyst estimates and negative operating and net income.
  • The company has a low dilution risk but faces medium liquidity risk.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$1.09B
Gross profit$138.8M
Operating income-$44.4M
Net income-$67.1M
R&D
SG&A
D&A
SBC
Operating cash flow$238.9M
CapEx-$25.1M
Free cash flow$97.2M
Total assets$1.38B
Total liabilities$939.0M
Total equity$441.9M
Cash & equivalents
Long-term debt$501.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$441.9M
Net cash-$501.2M
Current ratio0.6
Debt/Equity1.1
ROA-4.9%
ROE-15.2%
Cash conversion-3.6%
CapEx/Revenue-2.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric4139Activity
Op margin-4.1%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin-6.1%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin12.7%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-2.3%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity113.0%71.3% medp25 60.7% · p75 71.3%top quartile
Observations
IR observations
Last actual revenue942,569,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 23:33 UTC#f321fc17
Market quoteclose TWD 23.90 · shares 0.05B diluted
no public URL
2026-05-08 23:33 UTC#76d16792
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 12:03 UTCJob: 85500fdb